Asset Details
Do you wish to reserve the book?
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Do you wish to request the book?
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
2001
Overview
Mechanical left ventricular assist devices have been used as a bridge to cardiac transplantation, but not as long-term therapy. In this study of patients with severe heart failure who were not candidates for transplantation, left ventricular assist was compared with optimal medical therapy. The one-year survival rate was 52 percent in the device group and 25 percent in the medical-therapy group. The device permitted patients to be ambulatory and improved the quality of life.
In this study of patients with severe heart failure who were not candidates for transplantation, left ventricular assist was compared with optimal medical therapy. This study is an important step in the further development of artificial-heart technology.
Improving the survival and the quality of life of patients with end-stage heart failure has been the underlying goal of decades of research on mechanical circulatory-support devices. This effort was stimulated by the increasing prevalence of this disorder and its grave prognosis. Heart failure affects an estimated 4.7 million Americans, with 550,000 new cases diagnosed annually and annual cost estimates ranging from $10 billion to $40 billion.
1
,
2
The aggregate five-year survival rate of patients with heart failure is approximately 50 percent,
1
whereas the one-year mortality rate of those with advanced disease may exceed 50 percent.
3
Patients with mild-to-moderate heart . . .
Publisher
Massachusetts Medical Society
Subject
